{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:50:11Z","timestamp":1786989011312,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.euroneuro.2020.11.004","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T05:27:34Z","timestamp":1605245254000},"page":"75-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice"],"prefix":"10.1016","volume":"42","author":[{"given":"Molly A.","family":"Kwiatkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Z.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordy","family":"van Enkhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared W.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2020.11.004_bib0001","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1399-5618.2006.00363.x","article-title":"Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial","volume":"8","author":"Akhondzadeh","year":"2006","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0002","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1399-5618.2011.00936.x","article-title":"Striatal dopamine transporter availability in unmedicated bipolar disorder","volume":"13","author":"Anand","year":"2011","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0003","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mp.2017.16","article-title":"The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment","volume":"22","author":"Ashok","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0004","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0026-895X(25)09262-4","article-title":"Inhibition of receptor\/G protein coupling by suramin analogues","volume":"50","author":"Beindl","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.coph.2007.09.002","article-title":"Adenosine as a neuromodulator in neurological diseases","volume":"8","author":"BOISON","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0006","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/bj2510201","article-title":"Differential effects of suramin on the coupling of receptors to individual species of pertussis-toxin-sensitive guanine-nucleotide-binding proteins","volume":"251","author":"Butler","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0007","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.12m07985","article-title":"Effects of cigarette smoking on neuropsychological performance in mood disorders: A comparison between smoking and nonsmoking inpatients","volume":"74","author":"Caldirola","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0008","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/mp.2017.188","article-title":"Purinergic system in psychiatric diseases","volume":"23","author":"Cheffer","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0009","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0010","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.neuropharm.2011.10.010","article-title":"Involvement of estrogen receptors in the resveratrol-mediated increase in dopamine transporter in human dopaminergic neurons and in striatum of female mice","volume":"62","author":"Di Liberto","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0011","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuron.2008.09.009","article-title":"In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors","volume":"60","author":"Drenan","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0012","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41380-018-0219-x","article-title":"Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics","volume":"24","author":"Dulawa","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0013","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.283.5400.397","article-title":"Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity","volume":"283","author":"Gainetdinov","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0014","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/1568007023339184","article-title":"Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure","volume":"1","author":"Gentry","year":"2002","journal-title":"Curr. Drug Targets. CNS Neurol. Disord."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0166-4328(96)00065-4","article-title":"Serotonergic functions in arousal and motor activity","volume":"73","author":"Geyer","year":"1995","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0016","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0017","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archpsyc.61.11.1107","article-title":"Nicotine dependence and psychiatric disorders in the United States","volume":"61","author":"Grant","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0018","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/1096-8628(2001)9999:9999<::AID-AJMG1161>3.0.CO;2-8","article-title":"Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder","volume":"105","author":"Greenwood","year":"2001","journal-title":"Am. J. Med. Genet."},{"issue":"125\u201333","key":"10.1016\/j.euroneuro.2020.11.004_bib0019","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.mp.4001795","article-title":"Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples","volume":"11","author":"Greenwood","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2015.06.004","article-title":"Negative affective states and cognitive impairments in nicotine dependence","author":"Hall","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0021","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00213-011-2170-2","article-title":"Effect of methamphetamine dependence on inhibitory deficits in a novel human open-field paradigm","volume":"215","author":"Henry","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0022","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00213-017-4572-2","article-title":"Nicotine withdrawal-induced inattention is absent in alpha7 nAChR knockout mice","volume":"234","author":"Higa","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0023","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/sj.mp.4001730","article-title":"A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression","volume":"10","author":"Horschitz","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0024","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0026-895X(25)09974-2","article-title":"Identification of allosteric antagonists of receptor-guanine nucleotide-binding protein interactions","volume":"37","author":"Huang","year":"1990","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0025","doi-asserted-by":"crossref","DOI":"10.1111\/bdi.12319","article-title":"A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults","author":"Jackson","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0026","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1093\/hmg\/ddu285","article-title":"Inhibition of protein translation by the DISC1-Boymaw fusion gene from a Scottish family with major psychiatric disorders","volume":"23","author":"Ji","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0027","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pbb.2017.12.007","article-title":"Dopamine transporter knockdown mice in the behavioral pattern monitor: a robust, reproducible model for mania-relevant behaviors","volume":"178","author":"Kwiatkowski","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0028","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1124\/mol.104.006429","article-title":"Long-term nicotine treatment decreases striatal \u03b16* nicotinic acetylcholine receptor sites and function in mice","volume":"67","author":"Lai","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0029","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s002130050750","article-title":"Transdermal nicotine effects on attention","volume":"140","author":"Levin","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1054\/mehy.2001.1543","article-title":"Purinergic dysfunction in mania: an integrative model","volume":"58","author":"Machado-Vieira","year":"2002","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0031","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v69n0806","article-title":"A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0032","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1124\/jpet.114.213819","article-title":"Brexpiprazole II: Antipsychotic-like and procognitive effects of a novel serotonin-dopamine activity modulator","volume":"350","author":"Maeda","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0033","doi-asserted-by":"crossref","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0034","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00213-017-4543-7","article-title":"Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown\u2014a model of mania","volume":"234","author":"Milienne-Petiot","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0035","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jad.2009.04.018","article-title":"The quantitative assessment of motor activity in mania and schizophrenia","volume":"120","author":"Minassian","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0036","doi-asserted-by":"crossref","first-page":"e24185","DOI":"10.1371\/journal.pone.0024185","article-title":"Repeated assessment of exploration and novelty seeking in the human behavioral pattern monitor in bipolar disorder patients and healthy individuals","volume":"6","author":"Minassian","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0037","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.33","article-title":"Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy","volume":"4","author":"Naviaux","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0038","doi-asserted-by":"crossref","DOI":"10.1186\/2040-2392-6-1","article-title":"Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model","volume":"6","author":"Naviaux","year":"2015","journal-title":"Mol. Autism"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0039","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/acn3.424","article-title":"Low-dose suramin in autism spectrum disorder: a small, phase I\/II, randomized clinical trial","volume":"4","author":"Naviaux","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057380","article-title":"antipurinergic therapy corrects the autism-like features in the poly(IC) mouse model","volume":"8","author":"Naviaux","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0041","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/jpet.114.218578","article-title":"Acute effects of brexpiprazole on serotonin, dopamine, and norepinephrine systems: an in vivo electrophysiologic characterization","volume":"351","author":"Oosterhof","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0042","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/sj.bjp.0701842","article-title":"Inhibition of NMDA-gated ion channels by the P2 purinoceptor antagonists suramin and reactive blue 2 in mouse hippocampal neurones","volume":"124","author":"Peoples","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0043","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/archgenpsychiatry.2009.58","article-title":"A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men","volume":"66","author":"Perry","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0044","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/npp.2011.45","article-title":"Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder","volume":"36","author":"Pinsonneault","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pbb.2008.11.001","article-title":"Nicotine withdrawal disrupts new contextual learning","volume":"92","author":"Portugal","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0046","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0006-8993(93)90121-3","article-title":"Effects of systemic nicotine on serotonin release in rat brain","volume":"621","author":"Ribeiro","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0047","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1124\/mol.65.6.1526","article-title":"Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice","volume":"65","author":"Salminen","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0048","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.biopsych.2013.02.024","article-title":"Impulsivity is associated with uric acid: evidence from humans and mice","volume":"75","author":"Sutin","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0049","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbr.2012.04.045","article-title":"Four factors underlying mouse behavior in an open field","volume":"233","author":"Tanaka","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9758\/cpn.2015.13.1.1","article-title":"Tobacco use in bipolar disorder","volume":"13","author":"Thomson","year":"2015","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0051","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jad.2013.08.041","article-title":"Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder","volume":"155","author":"van Enkhuizen","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0052","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1017\/S1461145712001198","article-title":"Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice","volume":"16","author":"van Enkhuizen","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0053","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2014.05.063","article-title":"The catecholaminergic\u2013cholinergic balance hypothesis of bipolar disorder revisited","volume":"753","author":"van Enkhuizen","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0054","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0306-3623(83)90037-X","article-title":"Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors","volume":"14","author":"Westfall","year":"1983","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0055","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/npp.2010.192","article-title":"Efficacy of antimanic treatments: meta-analysis of randomized, controlled Trials","volume":"36","author":"Yildiz","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0056","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2015.03.019","article-title":"Investigating the mechanism(s) underlying switching between states in bipolar disorder","volume":"759","author":"Young","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0057","article-title":"Convergent neural substrates of inattention in bipolar disorder patients and dopamine transporter\u2010deficient mice using the 5\u2010choice CPT","author":"Young","year":"2019","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0058","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pbb.2010.03.014","article-title":"The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration","volume":"96","author":"Young","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0059","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbr.2012.11.028","article-title":"Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test","volume":"240","author":"Young","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0060","series-title":"Current Topics in Behavioral Neurosciences","first-page":"287","article-title":"Locomotor profiling from rodents to the clinic and back again","author":"Young","year":"2016"},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0061","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.neubiorev.2007.05.009","article-title":"A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor","volume":"31","author":"Young","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0062","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/0269881111400646","article-title":"Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania","volume":"25","author":"Young","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0063","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/msj.20042","article-title":"Bipolar disorder: candidate drug targets","volume":"75","author":"Zarate","year":"2008","journal-title":"Mt. Sinai J. Med. A J. Transl. Pers. Med."},{"key":"10.1016\/j.euroneuro.2020.11.004_bib0064","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1073\/pnas.98.4.1982","article-title":"Hyperactivity and impaired response habituation in hyperdopaminergic mice","volume":"98","author":"Zhuang","year":"2001","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X2030938X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X2030938X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:59:25Z","timestamp":1760378365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X2030938X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":64,"alternative-id":["S0924977X2030938X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.11.004","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}